Micheal Meng, MBA

Michael Meng is the Chief Executive Officer and Co-Founder of Stellar Health. Michael has invested in healthcare companies for the past decade and has years of experience working in the field. Prior to Stellar Health, Michael was a Principal at Apax Partners, a large-cap global private equity firm where he deployed C$3bn of capital. He has served on the board of companies, including Vyaire Medical, Medicomp, One Call Care Management, and TriZetto. In addition, he also serves on the board of the CUNY School of Public Health and Global Language Project. He received his bachelor’s degree from the University of Michigan and his MBA from Wharton.

Serge Saxonov, PhD

Serge Saxonov co-founded 10x Genomics in 2012. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company since inception. Prior to 10x Genomics, Serge was Vice President of Applications at Ouantalife, where he built products and defined the company's growth areas. Serge was the first employee at 23andMe, where he served as Founding Architect and Director of R&D. There he defined the initial concept of the product, built out the core technology, and drove strategy and execution of R&D functions. Serge received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics from Harvard College.

Armon Sharei, PhD

Armon Sharei is the Chief Executive Officer and Founder of Portal Bio, a cell engineering platform company. Previously he was the founder and CEO of SQZ Biotech (NYSE:$SQZ) where he led the company for 10 years - from founding to post-IPO and multiple clinical trial implementations. Dr. Sharei developed the Cell Squeeze® platform during his PhD work in chemical engineering at MIT. After his PhD, Dr. Sharei was a Ragon Institute postdoctoral Fellow at Harvard Medical School. He is co-author of over 20 peer-reviewed publications and inventor on over 20 patents.